Abstract
The transplantation of fresh or cryopreserved vascular allografts in patients with a prosthetic graft infection or critical limb ischemia is necessary for their limb salvage and, in many cases, represents a lifesaving procedure. While transplantation of fresh allografts has a long history in the Czech Republic, the standard use of cryopreserved vascular allografts was introduced into the clinical practice in 2011 as a result of the implementation of EU Directive 2004/23/EC into national legislation (Human Cell and Tissue Act No. 296/2008 Coll.). The authors present an organizational model based on cooperation between the majority of Czech Transplant Centers with a tissue establishment licensed by the national competent authority. In various points, we are addressing individual aspects of experimental and clinical studies which affect clinical practice. Based on experimental and clinical work, the first validation of cryopreserved arterial and venous grafts for clinical use was performed between 2011 and 2013. The growing number of centers participating in this programme led to a growing number of patients who underwent transplantation of vascular allografts. In 2015 the numbers of transplanted fresh versus cryopreserved allografts in the Czech Republic were almost equal. Cooperation of the participating centers in the Czech Republic with the licensed Tissue Establishment made it possible to achieve a full compliance with the European Union Directives, and harmonized national legal norms and assured a high quality of cryopreserved vascular allografts.
Similar content being viewed by others
References
Adamec M, Matia I, Janousek L (2011) Immunosuppression following venous allografts transplantations-the authors’ experience. Rozhl Chir 90(2):130–133
Bahnini A, Ruotolo C, Koskas F, Kieffer E (1991) In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months’ follow-up. J Vasc Surg 14(1):98–102
Carrel A (1912) Ultimate results of aortic transplantations. J Exp Med 15(4):389–392
Chiesa R, Astore D, Piccolo G, Melissano G, Jannello A et al (1998) Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg 12(5):457–462
Chlupac J, Filova E, Bacakova L (2009) Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol Res 58(2):119–139
Dubost C, Allary M (1951) Aneurysm of the abdominal aorta treated by resection and graft. Arch Mal Coeur Vaiss 44(9):848–851
Fellmer P, Matia I, Tautenhahn H-M, Jonas S (2011) Effect of legal regulations on the use of fresh arterial homografts. Probl Clin Pract. Gefässchirurgie 16:403–406
Fellmer PT, Matia I, Jonas S (2013) Arterial allografts in vascular surgery–best choice in cases of aortic graft infection?! Zentralbl Chir 138(5):530–535
Goffin YA, Van Hoeck B, Jashari R, Soots G, Kalmar P (2000) Banking of cryopreserved heart valves in Europe: assessment of 10 year operation in the European Homograft Bank (EHB). J Heart Valve Dis 9(2):207–214
Gross RE, Bill AH Jr, Peirce EC Jr (1949) Methods for preservation and transplantation of arterial grafts; observations on arterial grafts in dogs; report of transplantation of preserved arterial grafts in nine human cases. Surg Gynecol Obstet 88(6):689–701
Harlander-Locke MP, Harmon LK, Lawrence PF, Oderich GS, McCready RA et al (2014) The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg 59(3):669–674
Hrubý J, Špunda R, Měřička P, Mlček M, Splith K et al (2015) Influence of cryopreservation on antigenicity of aortal allografts in rats. Cryobiology 71(3):543
Jashari R, Van Hoeck B, Ngakam R, Goffin Y, Fan Y (2013) Banking of cryopreserved arterial allografts in Europe: 20 years of operation in the European Homograft Bank (EHB) in Brussels. Cell Tissue Bank. 14(4):589–599
Kieffer E, Gomes D, Chiche L, Fléron MH, Koskas F et al (2004) Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg 39(5):1009–1017
Kniemeyer HW, Torsello G, Hennes N, Grabitz K, Sandmann W (1994) Fresh homologous arterial transplant as aorto-iliac-femoral vascular replacement in prosthesis infection. Vasa 23(3):268–273
Matia I, Adamec M, Janousek L, Lipar K, Viklicky O (2006) Fresh arterial grafts as conduits for vascular reconstructions in transplanted patients. Eur J Vasc Endovasc Surg 32(5):549–556
Matia I, Janousek L, Marada T, Adamec M (2007) Cold-stored venous allografts in the treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 34(4):424–431
Matia I, Adamec M, Janousek L, Lipár K, Marada T et al (2010) Clinical experience with cold-preservation of venous and arterial allografts. Long-term outcomes. Rozhl Chir 89(1):45–54
Matia I, Fellmer P, Splith K, Varga M, Adamec M et al (2014) Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. Ann Transplant 12(19):225–232
Matia I, Hruby J, Spunda R, Adamec M, Varga M et al (2016) Influence of cryoconservation on antigenicity of arterial allografts: a review. Eur Surg 48(3):192–193
Měřička P, Straková H, Postupa J, Pospíšil J, Hřivňatský M et al (2008) The impact of changes of the European Union and National legislation on the practice of a tissue bank. In: Raposio E (ed) Tissue engineering and plastic surgery, I edn. Parma, Lulu.com, pp 57–70
Měřička P, Navrátil P, Špatenka J (2011) Legislativa dárcovství a odběrů tkání v České republice. Odběry orgánů k transplantaci.1 vyd. Karolinum, Praha, pp 223–239
Měřička P, Špaček M, Janoušek L, Dvořáček L, Štádler P et al (2015) Cryopreservation of vascular grafts for clinical use-retrospective analysis of pre-freezing factors with potential impact on the quality and safety of vascular transplantations. Cryobiology 71(3):546–547
Minga Lowampa E, Holemans C, Stiennon L, Van Damme H, Defraigne JO (2016) Late fate of cryopreserved arterial allografts. Eur J Vasc Endovasc Surg 52(5):696–702
Noel AA, Gloviczki P, Cherry KJ Jr, Safi H, Goldstone J et al (2002) United States cryopreserved aortic allograft Registry. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg 35(5):847–852
O’Connor S, Andrew P, Batt M, Becquemin JP (2006) A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 44(1):38–45
Prager M, Hölzenbein Th, Aslim E, Domenig K, Műhlbacher F, Kretscher G (2002) Fresh arterial homograft transplantation: a novel concept for critical limb ischaemia. Eur J Vasc Surg 24(4):314–321
Song YC, Khirabadi BS, Lightfoot F, Brockbank KGM, Taylor MJ (2000) Vitreous cryopreservation maintains the function of vascular grafts. Nat Biotechnol 18(3):296–299
Špunda R, Hrubý J, Adamec M, Varga M, Lindner J et al (2016) Cold-stored arterial allografts for in situ reconstruction of infected prosthetic grafts. Review of immunosuppressive protocols used in clinical practice. Eur Surg 48(Suppl 2):166–168
Szilagyi DE, Mc DR, Smith RF, Whitcomb JG (1957) Biologic fate of human arterial homografts. AMA Arch Surg. 75(4):506–527
Szilagyi DE, Smith RF, Elliott JP, Allen HM (1965) Long-term behavior of a dacron arterial substitute: clinical, roentgenologic and histologic correlations. Ann Surg 162(3):453–477
Szilagyi DE, Rodriguez FJ, Smith RF, Elliott JP (1970) Late fate of arterial allografts. Observations 6 to 15 years after implantation. Arch Surg 101(6):721–733
Teebken OE, Pichlmaier MA, Brand S, Haverich A (2004) Cryopreserved arterial allografts for in situ reconstruction of infected arterial vessels. Eur J Vasc Endovasc Surg 27(6):597–602
Touma J, Cochennec F, Parisot J, Fialaire Legendre A et al (2014) In situ reconstruction in native and prosthetic aortic infections using cryopreserved arterial allografts. Eur J Vasc Endovasc Surg 48(3):292–299
van Kats JP, van Tricht C, van Dijk A, van der Schans M, van den Bogaerdt A et al (2010) Microbiological examination of donated human cardiac tissue in heart valve banking. Eur J Cardiothorac Surg 37(1):163–169
Vogt PR, von Segesser LK, Goffin Y, Niederhauser U, Genoni M et al (1996) Eradication of aortic infections with the use of cryopreserved arterial homografts. Ann Thorac Surg 62(3):640–645
Vogt PR, Brunner-La Rocca HP, Carrel T, von Segesser LK, Ruef C et al (1998) Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg 116(6):965–972
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Špaček, M., Měřička, P., Janoušek, L. et al. Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. Cell Tissue Bank 19, 437–445 (2018). https://doi.org/10.1007/s10561-018-9691-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-018-9691-4